Literature DB >> 21449613

Solution NMR insights into docking interactions involving inactive ERK2.

Andrea Piserchio1, Mangalika Warthaka, Ashwini K Devkota, Tamer S Kaoud, Sunbae Lee, Olga Abramczyk, Pengyu Ren, Kevin N Dalby, Ranajeet Ghose.   

Abstract

The mitogen-activated protein (MAP) kinase ERK2 contains recruitment sites that engage canonical and noncanonical motifs found in a variety of upstream kinases, regulating phosphatases and downstream targets. Interactions involving two of these sites, the D-recruitment site (DRS) and the F-recruitment site (FRS), have been shown to play a key role in signal transduction by ERK/MAP kinases. The dynamic nature of these recruitment events makes NMR uniquely suited to provide significant insight into these interactions. While NMR studies of kinases in general have been greatly hindered by their large size and complex dynamic behavior leading to the suboptimal performance of standard methodologies, we have overcome these difficulties for inactive full-length ERK2 and obtained an acceptable level of backbone resonance assignments. This allowed a detailed investigation of the structural perturbations that accompany interactions involving both canonical and noncanonical recruitment events. No crystallographic information exists for the latter. We found that the chemical shift perturbations in inactive ERK2, indicative of structural changes in the presence of canonical and noncanonical motifs, are not restricted to the recruitment sites but also involve the linker that connects the N- and C-lobes and, in most cases, a gatekeeper residue that is thought to exert allosteric control over catalytic activity. We also found that, even though the canonical motifs interact with the DRS utilizing both charge-charge and hydrophobic interactions, the noncanonical interactions primarily involve the latter. These results demonstrate the feasibility of solution NMR techniques for a comprehensive analysis of docking interactions in a full-length ERK/MAP kinase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21449613      PMCID: PMC3103835          DOI: 10.1021/bi2000559

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  59 in total

1.  Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange.

Authors:  A N Hoofnagle; K A Resing; E J Goldsmith; N G Ahn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.

Authors:  A J Bardwell; L J Flatauer; K Matsukuma; J Thorner; L Bardwell
Journal:  J Biol Chem       Date:  2000-12-28       Impact factor: 5.157

Review 3.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

Review 4.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 5.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

6.  PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.

Authors:  E Formstecher; J W Ramos; M Fauquet; D A Calderwood; J C Hsieh; B Canton; X T Nguyen; J V Barnier; J Camonis; M H Ginsberg; H Chneiweiss
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

Review 7.  MAP kinases.

Authors:  Z Chen; T B Gibson; F Robinson; L Silvestro; G Pearson; B Xu; A Wright; C Vanderbilt; M H Cobb
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

8.  Purification of a model substrate for transcription factor phosphorylation by ERK2.

Authors:  W F Waas; K N Dalby
Journal:  Protein Expr Purif       Date:  2001-10       Impact factor: 1.650

9.  A conserved docking motif in MAP kinases common to substrates, activators and regulators.

Authors:  T Tanoue; M Adachi; T Moriguchi; E Nishida
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

Review 10.  The MAPK signalling pathways and colorectal cancer.

Authors:  Jing Yuan Fang; Bruce C Richardson
Journal:  Lancet Oncol       Date:  2005-05       Impact factor: 41.316

View more
  23 in total

1.  Examining docking interactions on ERK2 with modular peptide substrates.

Authors:  Sunbae Lee; Mangalika Warthaka; Chunli Yan; Tamer S Kaoud; Pengyu Ren; Kevin N Dalby
Journal:  Biochemistry       Date:  2011-10-18       Impact factor: 3.162

Review 2.  Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.

Authors:  Michael J Schnieders; Tamer S Kaoud; Chunli Yan; Kevin N Dalby; Pengyu Ren
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Structural basis for the regulation of the mitogen-activated protein (MAP) kinase p38α by the dual specificity phosphatase 16 MAP kinase binding domain in solution.

Authors:  Ganesan Senthil Kumar; Heiko Zettl; Rebecca Page; Wolfgang Peti
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

Review 4.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

5.  Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2.

Authors:  Andrea Piserchio; Mangalika Warthaka; Tamer S Kaoud; Kari Callaway; Kevin N Dalby; Ranajeet Ghose
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

6.  Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine.

Authors:  Mangalika Warthaka; Charles H Adelmann; Tamer S Kaoud; Ramakrishna Edupuganti; Chunli Yan; William H Johnson; Scarlett Ferguson; Clint D Tavares; Lindy J Pence; Eric V Anslyn; Pengyu Ren; Kenneth Y Tsai; Kevin N Dalby
Journal:  ACS Med Chem Lett       Date:  2014-10-17       Impact factor: 4.345

7.  Functional divergence caused by mutations in an energetic hotspot in ERK2.

Authors:  Clinton A Taylor; Kevin W Cormier; Shannon E Keenan; Svetlana Earnest; Steve Stippec; Chonlarat Wichaidit; Yu-Chi Juang; Junmei Wang; Stanislav Y Shvartsman; Elizabeth J Goldsmith; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-11       Impact factor: 11.205

8.  Structural basis of p38α regulation by hematopoietic tyrosine phosphatase.

Authors:  Dana M Francis; Bartosz Różycki; Dorothy Koveal; Gerhard Hummer; Rebecca Page; Wolfgang Peti
Journal:  Nat Chem Biol       Date:  2011-11-06       Impact factor: 15.040

9.  Docking interactions of hematopoietic tyrosine phosphatase with MAP kinases ERK2 and p38α.

Authors:  Andrea Piserchio; Dana M Francis; Dorothy Koveal; Kevin N Dalby; Rebecca Page; Wolfgang Peti; Ranajeet Ghose
Journal:  Biochemistry       Date:  2012-10-05       Impact factor: 3.162

10.  A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Authors:  Rachel M Sammons; Nicole A Perry; Yangmei Li; Eun Jeong Cho; Andrea Piserchio; Diana P Zamora-Olivares; Ranajeet Ghose; Tamer S Kaoud; Ginamarie Debevec; Chandra Bartholomeusz; Vsevolod V Gurevich; Tina M Iverson; Marc Giulianotti; Richard A Houghten; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.